Introduction
Whipple's disease is a rare, systemic illness which usually affects middle-aged males. It is characterized morphologically by periodic acid-Schiff staining macrophages in virtually every organ system but maximally involving the lamina propria of the proximal small intestine and the mesenteric lymph nodes. In a recent review, 238 patients were reported as having Whipple's disease, of whom only thirtythree were female (Miksche et al., 1974 
Histology
The dissecting microscope appearance was of stout, swollen, finger-like or tongue-like villi. Under light microscopy ( Fig. 1) (Whipple, 1907; Maizel, Ruffin and Dobbins, 1970) . The pathological findings in the jejunal biopsy and mesenteric lymph node fulfil the accepted criteria for its diagnosis (Maizel et al., 1970 ). In the patient described, there was evidence of a functional defect in both the proximal small intestine (abnormal iron and xylose absorption) and distal small intestine (abnormal double-isotope Schilling test).
Only two other cases of significant malabsorption of vitamin B12 have been documented (Gross et al., 1959; Paul, 1967) , involvement of the distal small bowel being usually regarded as less severe than proximal disease (Maizel et al., 1970) .
Immunological studies of Whipple's disease have emphasized the cellular findings (Martin et al., 1972) . The significant lymphopenia initially present in the patient described affected both T and B lymphocyte sub-populations. This lymphopenia and the return to normal levels on treatment led Pastor and Geerken (1973) (Groll et al., 1972; Pastor and Geerken, 1973) . In vitro lymphocyte transformation responses to various mitogens and antigens were impaired both before and after treatment (Table 1) , suggesting the defect was primary. This is supported by the fact that eleven of a total of thirteen patients studied have shown depressed responsiveness to phytohaemagglutinin in the post-treatment phase (Maxwell et fal., 1968; Watson, Maxwell and Ferguson, 1969; Martin et al., 1972; Groll et al., 1972; Pastor and Geerken, 1973) .
Where assessment of splenic size in Whipple's disease has been possible, the spleen was usually normal, although splenomegaly has been documented in at least six patients in the literature (Maizel et al., 1970 (Soothill, 1975 (Case Records, 1971; Pastor and Geerken, 1973) . Hypogammaglobulinaemia has been reported in four patients with Whipple's disease (Sandor and Kozmer, 1967; Martel and Hodges, 1959; Anton, 1961; Cochran et al., 1973) (Maxwell et al., 1968; Groll et al., 1972) or elevated (Pastor and Geerken, 1973 Since Paulley (1952) reported the successful use of antibiotics, a variety of different drugs has been tried and found effective to varying degrees (Miksche et al., 1974) . Co-trimoxazole was initially used in the present patient to treat her contaminated small-bowel syndrome, but it also appears to have been effective in the treatment of the Whipple's disease (Fig. 2) ; Elsborg, Gravgaard and Jacobsen (1975) have also documented a case in whom this drug was used beneficially.
Any hypothesis of the aetiology of Whipple's disease must take into account its rarity, predilection for male Caucasians, predominant involvement of the gastrointestinal tract, and the histological observation of bacilliform bodies in the intestinal lesion. The true role of micro-organisms in this condition is not clearly defined but a cell-wall deficient form of an o-haemolytic streptococcus has recently been isolated from prolonged monolayer cultures of a lymph node taken from a patient with Whipple's disease (Clancy et al., 1975) . There is also some suggestion that host factors may be of prime importance. Evidence of impaired cell-mediated immunity in individuals with Whipple's disease (Maxwell et al., 1968; Watson et al., 1969; Martin et al., 1972; Groll et al., 1972; Pastor and Geerken, 1973) raises the possibility that a primary immune deficit predisposes to the development of the condition and the findings in the present patient support this suggestion.
Levamisole, an effective anthelmintic, has been shown to have immunopotentiation effects (Leading Article, 1975) . In man, it has been reported as restoring delayed hypersensitivity responses in individuals with anergy associated with old age and malignant disease (Tripodi, Parks and Brugmans, 1973; Leading Article 1975) . Clinical usefulness for levamisole has been claimed in a range of disorders (Leading Article, 1975) and in vitro, levamisole appears to activate functionally defective T cells (Verhaegen et al., 1975; Biniaminov and Ramot, 1975) . No significant improvement in the present patient's lymphocyte transformation responsiveness or cutaneous anergy was seen after 4 months of levamisole therapy (Table 2 ). This lack of response again suggests that the cellular defect in this patient was primary. Based on the evidence in the literature and the experience gained from the present case, it seems possible that impaired cell-mediated immunity is directly involved in the pathogenesis of Whipple's disease. 
